(Q28235453)
Statements
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer (English)
R Pérez Carrión
V Alberola Candel
F Calabresi
R T Michel
R Santos
T Delozier
P Goss
L Mauriac
F Feuilhade